Citations (183)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Marie H. Larsen, Yndis A. Staalesen Strumse, Christine R. Borge, Marit H. Andersen & Astrid K. Wahl. (2022) Relevant associations between alexithymia and health-literacy in persons with psoriasis. Journal of Dermatological Treatment 33:1, pages 380-388.
Read now
Read now
Deepak M. W. Balak, Jose-Manuel Carrascosa, Stamatis Gregoriou, Piergiacomo Calzavara-Pinton, Anthony Bewley, Joana Antunes, Martin E. Nyeland, Marta G. Viola, Laura M. Sawyer & Lidia Becla. (2021) Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries. Journal of Dermatological Treatment 32:7, pages 701-708.
Read now
Read now
Busra Aydin, Kazim Yalcin Arga & Ayse Serap Karadag. (2020) Omics-Driven Biomarkers of Psoriasis: Recent Insights, Current Challenges, and Future Prospects. Clinical, Cosmetic and Investigational Dermatology 13, pages 611-625.
Read now
Read now
Annika S Silfvast-Kaiser, Katie B Homan & Bobbak Mansouri. (2019) A narrative review of psoriasis and multiple sclerosis: links and risks. Psoriasis: Targets and Therapy 9, pages 81-90.
Read now
Read now
Shinichi Imafuku, Ataru Nakano, Hidetoshi Dakeshita, Junlong Li, Keith A. Betts & Annie Guerin. (2018) Number needed to treat and costs per responder among biologic treatments for moderate-to-severe plaque psoriasis in Japan. Journal of Dermatological Treatment 29:1, pages 24-31.
Read now
Read now
Maurizio Pompili, Marco Innamorati, Alberto Forte, Denise Erbuto, Dorian A. Lamis, Alessandra Narcisi, Claudia Rea, Diego Orsini, Andrea D’Arino, Annalisa Arcese, Samantha Bellini, Sara Trovarelli, Gianluca Serafini, Mario Amore, Antonio Costanzo & Paolo Girardi. (2017) Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders. International Journal of Psychiatry in Clinical Practice 21:3, pages 209-214.
Read now
Read now
Toral S. Vaidya, Robin S. Lewallen & Steven R. Feldman. (2016) Erythrodermic psoriasis and severe hypotension requiring intensive care unit hospitalization: Poor treatment outcome as a result of poor adherence. Journal of Dermatological Treatment 27:2, pages 134-135.
Read now
Read now
Lynda Grine & Jo Lambert. (2016) Psoriasis: burning down the host. Journal of Dermatological Treatment 27:1, pages 1-1.
Read now
Read now
Nagaraj M. Kulkarni, Mallikarjun S. Jaji, Pranesha Shetty, Yeshwant V. Kurhe, Shilpee Chaudhary, G. Vijaykant, J. Raghul, Santosh L. Vishwakarma, B. Navin Rajesh, Jeyamurugan Mookkan, Uma Maheswari Krishnan & Shridhar Narayanan. (2015) A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation. Pharmaceutical Biology 53:8, pages 1110-1117.
Read now
Read now
Vanessa G. Hafez, Manal Bosseila, Mona R. E. Abdel Halim, Olfat G. Shaker, Manal Kamal & Heba Sherif Kareem. (2015) Clinical effects of “pioglitazone”, an insulin sensitizing drug, on psoriasis vulgaris and its co-morbidities, a double blinded randomized controlled trialx1. Journal of Dermatological Treatment 26:3, pages 208-214.
Read now
Read now
G. Girolomoni, C. E. M. Griffiths, J. Krueger, F. O. Nestle, J-F. Nicolas, J. C. Prinz, L. Puig, M. Ståhle, P. C. M. van de Kerkhof, M. Allez, P. Emery & C. Paul. (2015) Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper. Journal of Dermatological Treatment 26:2, pages 103-112.
Read now
Read now
Robert Strohal, Sergio Chimenti, Gino Antonio Vena & Giampiero Girolomoni. (2013) Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence. Journal of Dermatological Treatment 24:3, pages 199-208.
Read now
Read now
Juliana L Basko-Plluska & Vesna Petronic-Rosic. (2012) Psoriasis: epidemiology, natural history, and differential diagnosis. Psoriasis: Targets and Therapy 2, pages 67-76.
Read now
Read now
Hans R. Preus, Pejman Khanifam, Kristin Kolltveit, Cato Mørk & Per Gjermo. (2010) Periodontitis in psoriasis patients. A blinded, case-controlled study. Acta Odontologica Scandinavica 68:3, pages 165-170.
Read now
Read now
Giorgio L Colombo, Sergio Di Matteo, Ketty Peris, Maria Concetta Fargnoli, Maria Esposito, Annamaria Mazzotta & Sergio Chimenti. (2009) A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy. ClinicoEconomics and Outcomes Research 1, pages 53-59.
Read now
Read now
Thao U Nguyen & John Koo. (2009) Etanercept in the treatment of plaque psoriasis. Clinical, Cosmetic and Investigational Dermatology 2, pages 77-84.
Read now
Read now
Ben P Chapman & Jan Moynihan. (2009) The brain–skin connection: role of psychosocial factors and neuropeptides in psoriasis. Expert Review of Clinical Immunology 5:6, pages 623-627.
Read now
Read now
Andrew P. Yu, Jackson Tang, Jipan Xie, Eric Q. Wu, Shiraz R. Gupta, Yanjun Bao & Parvez M. Mulani. (2009) Economic burden of psoriasis compared to the general population and stratified by disease severity. Current Medical Research and Opinion 25:10, pages 2429-2438.
Read now
Read now
Abby S. Van Voorhees & Richard Fried. (2009) Depression and Quality of Life in Psoriasis. Postgraduate Medicine 121:4, pages 154-161.
Read now
Read now
Mohammad KA Basra & Muhammad Shahrukh. (2009) Burden of skin diseases. Expert Review of Pharmacoeconomics & Outcomes Research 9:3, pages 271-283.
Read now
Read now
Articles from other publishers (163)
Stacie Hudgens, Amy Howerter, Shannon Keith, Colby Evans & Corey Pelletier. (2023) Development and validation of a psoriasis treatment acceptability measure through group concept mapping. Health and Quality of Life Outcomes 21:1.
Crossref
Crossref
Ratnam Sreya, Shweta Nene, Vrushali Pathade, Shashi Bala Singh & Saurabh Srivastava. (2023) Emerging trends in combination strategies with phototherapy in advanced psoriasis management. Inflammopharmacology 31:4, pages 1761-1778.
Crossref
Crossref
Martina Krušič, Gregor Jezernik & Uroš Potočnik. (2023) Gene Ontology Analysis Highlights Biological Processes Influencing Responsiveness to Biological Therapy in Psoriasis. Pharmaceutics 15:8, pages 2024.
Crossref
Crossref
Po-Ying Wu, Chia-Chen Kao & Shwu-Jiuan Sheu. (2022) Cooperation with rheumatologists on intensive systemic treatment for psoriatic arthritis-related panuveitis with retinal vasculitis: a case report. BMC Ophthalmology 22:1.
Crossref
Crossref
Seema Chhabra, Smrity Sahu, Keshav Sharma, Maryada Sharma, Lekha Rani, Ranjana Minz & Sunil Dogra. 2022. Psoriasis - New Research. Psoriasis - New Research.
Parwaaz Matharoo, Saurabh Sharma, Jasleen Kaur & Roopam Bassi. (2022) Comparison of the efficacy of microneedling combined with 5-fluorouracil 5% cream versus microneedling combined with tacrolimus 0.1% ointment in the treatment of vitiligo. TURKDERM 56:2, pages 64-69.
Crossref
Crossref
Phoebe Wellmann, Christian Kromer, Ralf Siemer, Selina Klein, Johannes Mohr, Undine Lippert, Andreas Pinter, Dagmar Wilsmann-Theis & Rotraut Mössner. (2022) Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso. Vaccines 10:7, pages 1005.
Crossref
Crossref
Vikram K. Mahajan, Narvir S. Chauhan, Baldev S. Rana, Karaninder S. Mehta, Sheenam Hooda, Pushpinder S. Chauhan & Amisha Kukreja. (2022) The Association Between Chronic Plaque Psoriasis and Nonalcoholic Fatty Liver Disease in Indian Patients: Results of a Pilot Study. Journal of Clinical and Experimental Hepatology 12:3, pages 785-792.
Crossref
Crossref
Lis Cordingley, Pauline A Nelson, Linda Davies, Darren Ashcroft, Christine Bundy, Carolyn Chew-Graham, Anna Chisholm, Jamie Elvidge, Matthew Hamilton, Rachel Hilton, Karen Kane, Christopher Keyworth, Alison Littlewood, Karina Lovell, Mark Lunt, Helen McAteer, Dionysios Ntais, Rosa Parisi, Christina Pearce, Martin Rutter, Deborah Symmons, Helen Young & Christopher EM Griffiths. (2022) Identifying and managing psoriasis-associated comorbidities: the IMPACT research programme. Programme Grants for Applied Research 10:3, pages 1-240.
Crossref
Crossref
Vivek Choudhary, Etsubdenk Ajebo, Rawipan Uaratanawong, Shinjini C Spaulding, Sarah Hossack, Xunsheng Chen, Jianrui Xu, Mrunal Choudhary, Debra L Irsik, Carlos M Isales & Wendy B Bollag. (2022) Loss of Indoleamine-2,3-Dioxygenase-1 (IDO1) in Knockout Mice Does Not Affect the Development of Skin Lesions in the Imiquimod-Induced Mouse Model of Psoriasis. International Journal of Tryptophan Research 15, pages 117864692210781.
Crossref
Crossref
Fernando Valenzuela & Rodrigo Flores. 2022. Textbook of Dermatologic Ultrasound. Textbook of Dermatologic Ultrasound
345
365
.
Daciana Branisteanu, Ruxandra Pirvulescu, Alina Spinu, Elena Porumb, Mihaela Cojocaru, Alin Nicolescu, Daniel Branisteanu, Catalina Branisteanu, Andreea Dimitriu, Anisia Alexa & Mihaela Toader. (2021) Metabolic comorbidities of psoriasis (Review). Experimental and Therapeutic Medicine 23:2.
Crossref
Crossref
Zita Szentkereszty-Kovács, Szilvia Fiatal, Eszter Anna Janka, Dóra Kovács, Andrea Szegedi, Éva Remenyik & Dániel Törőcsik. (2021) Leptin Receptor (rs1137101) and Brain-Derived Neurotrophic Factor (rs925946) Gene Variants Are Associated with Obesity in the Early- but Not in the Late-Onset Population of Hungarian Psoriatic Patients. Life 11:10, pages 1086.
Crossref
Crossref
Vivek Choudhary, Ismail Kaddour-Djebbar, Victoria E. Custer, Rawipan Uaratanawong, Xunsheng Chen, Elyssa Cohen, Rong Yang, Etsubdenk Ajebo, Sarah Hossack & Wendy B. Bollag. (2021) Glycerol Improves Skin Lesion Development in the Imiquimod Mouse Model of Psoriasis: Experimental Confirmation of Anecdotal Reports from Patients with Psoriasis. International Journal of Molecular Sciences 22:16, pages 8749.
Crossref
Crossref
Mark J. Schwade, Lillie Tien, Jennifer L. Waller, Loretta S. Davis, Stephanie L. Baer, Azeem Mohammed, Lufei Young, Mufaddal F. Kheda & Wendy B. Bollag. (2021) Treatment of psoriasis in end-stage renal disease patients is associated with decreased mortality: A retrospective cohort study. The American Journal of the Medical Sciences 362:1, pages 24-33.
Crossref
Crossref
Ehizogie Edigin, Jennifer Asotibe, Precious Obehi Eseaton, Olukayode Ahmed Busari, Ikechukwu Achebe, Asim Kichloo, Shakeel Jamal & Axi Patel. (2023) Coexisting Psoriasis is Associated with An Increased Risk of Hospitalization for Patients with Inflammatory Bowel Disease: An Analysis of the National Inpatient Sample Database. Journal of Investigative Medicine 69:4, pages 857-862.
Crossref
Crossref
Ashwani Rana, Vikram K. Mahajan, Karaninder S. Mehta, Pushpinder S. Chauhan, Mukul Kumar, Anuj Sharma, Reena Sharma, Niharika Dhattarwal & Megha Sondhi. (2020) Cardiomyopathy and echocardiographic abnormalities in Indian patients with psoriasis: Results of a pilot study. International Journal of Clinical Practice 75:3.
Crossref
Crossref
Mark G. Lebwohl, Craig L. Leonardi, Nehal N. Mehta, Alice B. Gottlieb, Alan M. Mendelsohn, Jeff Parno, Stephen J. Rozzo & M. Alan Menter. (2021) Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2). Journal of the American Academy of Dermatology 84:2, pages 398-407.
Crossref
Crossref
Neda Adibi & RezaM Robati. (2021) Skin and metabolic syndrome: A review of the possible associations. Journal of Research in Medical Sciences 26:1, pages 16.
Crossref
Crossref
Michele Fabrazzo, Salvatore Cipolla, Simona Signoriello, Alessio Camerlengo, Giulia Calabrese, Giulia Maria Giordano, Giuseppe Argenziano & Silvana Galderisi. (2021) A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa. European Psychiatry 64:1.
Crossref
Crossref
Niharika Dhattarwal, Vikram K. Mahajan, Karaninder S. Mehta, Pushpinder S. Chauhan, Rajinder S. Yadav, Satya Bhushan Sharma, Anuj Sharma, Reena Sharma, Ashwani Rana & Megha Sondhi. (2020) The association of anti‐gliadin and anti‐transglutaminase antibodies and chronic plaque psoriasis in Indian patients: Preliminary results of a descriptive cross‐sectional study. Australasian Journal of Dermatology 61:4.
Crossref
Crossref
N. N. Potekaev, O. V. Zhukova & S. I. Artemyeva. (2020) Psoriasis: a personalized approach to therapy. The preferred choice of systemic agents considering comorbid pathologies. Meditsinskiy sovet = Medical Council:12, pages 28-34.
Crossref
Crossref
Sohrab Salimi, Paul S. Yamauchi, Rohini Thakur, Jeffrey M. Weinberg, Leon Kircik, Ayman Abdelmaksoud, Uwe Wollina, Torello Lotti, Aseem Sharma, Stephan Grabbe & Mohamad Goldust. (2020) Interleukin 23p19 inhibitors in chronic plaque psoriasis with focus on mirikizumab: A narrative review. Dermatologic Therapy 33:4.
Crossref
Crossref
Kirk Geale, Martin Henriksson, Jussi Jokinen & Marcus Schmitt-Egenolf. (2020) Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study. JAMA Dermatology 156:7, pages 795.
Crossref
Crossref
Liudmyla V. Khimion & Alina V. Boiko. (2020) FEATURES OF THE INTERCONNECTION OF TRADITIONAL RISK FACTORS AND IL-10 WITH THE ACTIVITY OF THE INFLAMMATORY PROCESS AND ATHEROSCLEROSIS DEVELOPMENT IN PATIENTS WITH PSORIATIC ARTHRITIS. Wiadomości Lekarskie 73:5, pages 914-919.
Crossref
Crossref
Giulia Merlo, Emanuele Cozzani, Martina Burlando, Stefano Calvieri, Concetta Potenza, Luca Stingeni, Giorgio Filosa, Monica Pau, Marco Simonacci, Marzia Caproni & Aurora Parodi. (2020) Effects of TNFα inhibitors in patients with psoriasis and metabolic syndrome: a preliminary study. Giornale Italiano di Dermatologia e Venereologia 155:1.
Crossref
Crossref
L. V. Khimion & A. V. Boiko. (2020) ТРАДИЦІЙНІ ФАКТОРИ РИЗИКУ ТА ІНТЕРЛЕЙКІН-10 У РОЗВИТКУ ЗАПАЛЕННЯ ТА АТЕРОСКЛЕРОЗУ В ХВОРИХ НА ПСОРІАТИЧНИЙ АРТРИТ. Здобутки клінічної і експериментальної медицини:4, pages 136-143.
Crossref
Crossref
V. A. Akhmedov & T. I. Melikov. (2020) Non-alcoholic fatty liver disease and psoriasis: random combination or regular relationship?. Medical alphabet 4:38, pages 5-8.
Crossref
Crossref
S.G. Lykova, M.A. Morzhanaeva, O.B. Nemchaninova & E.V. Svechnikova. (2020) Psoriasis in patients with metabolic syndrome: clinical aspects of the problem. Klinicheskaya dermatologiya i venerologiya 19:2, pages 214.
Crossref
Crossref
Alan Menter, Kelly M. Cordoro, Dawn M.R. Davis, Daniela Kroshinsky, Amy S. Paller, April W. Armstrong, Cody Connor, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Dario Kivelevitch, Neil J. Korman, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Sylvia L. Parra, Arun L. Pathy, Elizabeth A. Farley Prater, Reena N. Rupani, Michael Siegel, Benjamin Stoff, Bruce E. Strober, Emily B. Wong, Jashin J. Wu, Vidhya Hariharan & Craig A. Elmets. (2020) Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. Journal of the American Academy of Dermatology 82:1, pages 161-201.
Crossref
Crossref
Л. В. Хіміон & А. В. Бойко. (2019) The Role of Traditional Risk Factors and Inflammation Activity in Atherosclerosis Development in Psoriatic Arthritis Patients. Family medicine:5-6, pages 59-63.
Crossref
Crossref
Л. В. Хіміон & А. В. Бойко. (2019) IL-10, Inflammation and Atherosclerosis in Psoriatic Arthritis Patients. Family medicine:5-6, pages 43-45.
Crossref
Crossref
L. S. Kruglova, A. N. Lvov, A. V. Kagramanova & O. V. Knyazev. (2019) Psoriasis and inflammatory bowel diseases: pathogenetic pathways and the choice of biologic therapy (a literature review). Almanac of Clinical Medicine 47:6, pages 568-578.
Crossref
Crossref
José Alexandre Mendonça, Sibel Zehra Aydin & Maria-Antonietta D’Agostino. (2019) The use of ultrasonography in the diagnosis of nail disease among patients with psoriasis and psoriatic arthritis: a systematic review. Advances in Rheumatology 59:1.
Crossref
Crossref
N. S. Rudneva, T. G. Sadunashvili, Ya. Yu. Chumakova & E. V. Natarova. (2019) Certolizumab pegol for treatment of severe plaque psoriasis: local experience. Medical alphabet 2:26, pages 34-40.
Crossref
Crossref
M.H. Larsen, Y.A.S. Strumse, C.R. Borge, R. Osborne, M.H. Andersen & A.K. Wahl. (2019) Health literacy: a new piece of the puzzle in psoriasis care? A cross‐sectional study. British Journal of Dermatology 180:6, pages 1506-1516.
Crossref
Crossref
Erwin Dreesen & Ann Gils. (2019) Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory Diseases. Therapeutic Drug Monitoring 41:2, pages 131-141.
Crossref
Crossref
L. Skov, S.F. Thomsen, L.E. Kristensen, R. Dodge, M.S. Hedegaard & J. Kjellberg. (2018) Cause‐specific mortality in patients with psoriasis and psoriatic arthritis. British Journal of Dermatology 180:1, pages 100-107.
Crossref
Crossref
Cacilda S. Souza, Caio C. S. de Castro, Francisca R. O. Carneiro, Jane M. N. Pinto, Lincoln H. Z. Fabricio, Luna Azulay-Abulafia, Ricardo Romiti, Tania F. Cestari, Cláudia E. Suzuki, Priscila M. Biegun, Luciana S. Guedes & Luiza K. M. Oyafuso. (2019) Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence. The Journal of Dermatology 46:1, pages 3-10.
Crossref
Crossref
Alexey A. Kubanov, Andrey L. Bakulev, Tatiana V. Fitileva, Evgenia Novoderezhkina, Isabelle Gilloteau, Haijun Tian, Tanya Howe & Guilhem Pietri. (2018) Disease Burden and Treatment Patterns of Psoriasis in Russia: A Real-World Patient and Dermatologist Survey. Dermatology and Therapy 8:4, pages 581-592.
Crossref
Crossref
Yun Fu, Cheng-Han Lee & Ching-Chi Chi. (2018) Association of Psoriasis With Inflammatory Bowel Disease. JAMA Dermatology 154:12, pages 1417.
Crossref
Crossref
Hyun-keun Kim, Min Bae, Seonung Lim, Wonwoo Lee & Sunyoung Kim. (2018) A Water-Soluble Extract from Actinidia arguta Ameliorates Psoriasis-Like Skin Inflammation in Mice by Inhibition of Neutrophil Infiltration. Nutrients 10:10, pages 1399.
Crossref
Crossref
Sauzanne Khalilieh, Azher Hussain, Diana Montgomery, Vanessa Levine, Peter M. Shaw, Inga Bodrug, Lally Mekokishvili, Candice Bailey-Smith, Xiaoli S. Glasgow, Amy Cheng, Monika Martinho & Marian Iwamoto. (2018) Effect of tildrakizumab (MK-3222), a high affinity, selective anti-IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis. British Journal of Clinical Pharmacology 84:10, pages 2292-2302.
Crossref
Crossref
Katerina Damevska, Katlein França, Torello Lotti, Suzana Nikolovska & Nora Pollozhani. (2018) Complementary and integrative therapies for psoriasis: Looking forward. Dermatologic Therapy 31:5, pages e12627.
Crossref
Crossref
A. L. Bakulev, T. V. Fitileva, E. А. Novodezerkina, I. Gilloteau, Н. Tian, T. Howe & G. Pietri. (2018) Psoriasis: clinical and epidemiological features and therapy issues. Vestnik dermatologii i venerologii 94:3, pages 67-76.
Crossref
Crossref
Misty G. Eleryan, Sophia Akhiyat, Olabola Awosika, Kurt Wenk, Monica Rengifo-Pardo, Lisa W. Martin & Alison Ehrlich. (2018) A Case–Control Study to Evaluate Serum Lipoprotein Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis. Journal of Psoriasis and Psoriatic Arthritis 3:3, pages 88-93.
Crossref
Crossref
C.E.M. GriffithsS.-J. Jo, L. Naldi, R. Romiti, E. Guevara-Sangines, T. HoweG. PietriI. Gilloteau, C. Richardson, H. TianM. Augustin. (2018) A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey. British Journal of Dermatology 179:1, pages 173-181.
Crossref
Crossref
Jane Grills. (2018) Interleukin-23 in Psoriasis: Integrating New Therapies in the Current Treatment Landscape. European Medical Journal, pages 22-29.
Crossref
Crossref
Lawrence F. Eichenfield, Amy S. Paller, Wynnis L. Tom, Jeffrey Sugarman, Adelaide A. Hebert, Sheila Fallon Friedlander, Elaine Siegfried, Nanette Silverberg & Kelly M. Cordoro. (2018) Pediatric psoriasis: Evolving perspectives. Pediatric Dermatology 35:2, pages 170-181.
Crossref
Crossref
Tuba Sevimoglu, Beste Turanli, Ceyhun Bereketoglu, Kazim Yalcin Arga & Ayse Serap Karadag. (2018) Systems biomarkers in psoriasis: Integrative evaluation of computational and experimental data at transcript and protein levels. Gene 647, pages 157-163.
Crossref
Crossref
Mark G. Lebwohl, Kim A. Papp, Lauren B. Marangell, John Koo, Andrew Blauvelt, Melinda Gooderham, Jashin J. Wu, Shipra Rastogi, Susan Harris, Radhakrishnan Pillai & Robert J. Israel. (2018) Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials. Journal of the American Academy of Dermatology 78:1, pages 81-89.e5.
Crossref
Crossref
Steven R. Feldman, Haijun Tian, Isabelle Gilloteau, Patrick Mollon & Meng Shu. (2017) Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database. BMC Health Services Research 17:1.
Crossref
Crossref
Houshang Nemati, Mohammad-Hosein Ghahramani, Reza Faridi-Majidi, Babak Izadi, Gholamreza Bahrami, Seyed-Hamid Madani & Gholamreza Tavoosidana. (2017) Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis. Journal of Controlled Release 268, pages 259-268.
Crossref
Crossref
Janet Fricker. (2017) Tackling the Inflammatory Burden of Psoriasis: A Multidisciplinary Approach. European Medical Journal, pages 27-35.
Crossref
Crossref
David Fiorentino, Vincent Ho, Mark G. Lebwohl, Luiz Leite, Lori Hopkins, Claudia Galindo, Kavitha Goyal, Wayne Langholff, Steven Fakharzadeh, Bhaskar Srivastava & Richard G. Langley. (2017) Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry. Journal of the American Academy of Dermatology 77:5, pages 845-854.e5.
Crossref
Crossref
Daniel Pietrzak, Aldona Pietrzak, Dorota Krasowska, Andrzej Borzęcki, Kinga Franciszkiewicz-Pietrzak, Beata Polkowska-Pruszyńska, Maja Baranowska & Kristian Reich. (2017) Digestive system in psoriasis: an update. Archives of Dermatological Research 309:9, pages 679-693.
Crossref
Crossref
J. Bagel, S. Tyring, K.C. Rice, D.H. Collier, G. Kricorian, J. Chung, J. Iles, B.S. Stolshek, A. Kaliyaperumal & K.A. Papp. (2017) Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab. British Journal of Dermatology 177:2, pages 411-418.
Crossref
Crossref
A. Chisholm, P.A. Nelson, C.J. Pearce, A.J. Littlewood, K. Kane, A.L. Henry, R. Thorneloe, M.P. Hamilton, J. Lavallee, M. Lunt, C.E.M. Griffiths, L. Cordingley & C. Bundy. (2017)
Motivational interviewing-based training enhances clinicians’ skills and knowledge in psoriasis: findings from the Pso Well
®
study
. British Journal of Dermatology 176:3, pages 677-686.
Crossref
Crossref
Abhishek Chaturvedi, Amit K. Dey, Aditya A. Joshi & Nehal N. Mehta. (2017) Vascular Inflammation Imaging in Psoriasis. Current Cardiovascular Imaging Reports 10:2.
Crossref
Crossref
Michelle Larissa Zini Lise, Talita Siara Almeida Baptista, Laura Esteves Petersen, Moisés Evandro Bauer, Cláudia Almeida Lopes Ungaretti, Elton Torres, Karen Harter & Henrique Luiz Staub. (2017) Subclinical atherogenesis in patients with mild psoriasis: A role for IL-6?. Revista da Associação Médica Brasileira 63:9, pages 747-752.
Crossref
Crossref
Christopher E. M. Griffiths, Peter van de Kerkhof & Magdalena Czarnecka-Operacz. (2017) Psoriasis and Atopic Dermatitis. Dermatology and Therapy 7:S1, pages 31-41.
Crossref
Crossref
Anna Chapman & Yasser El Miedany. 2017. Comorbidity in Rheumatic Diseases. Comorbidity in Rheumatic Diseases
81
124
.
Guy Shalom, Jacob Dreiher & Arnon Cohen. (2016) Psoriasis and obstructive sleep apnea. International Journal of Dermatology 55:11, pages e579-e584.
Crossref
Crossref
Christine Bundy & Lis Cordingley. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
10
.
April W. Armstrong, Keith A. Betts, Murali Sundaram, Darren Thomason & James E. Signorovitch. (2016) Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naïve patients with psoriasis. Journal of the American Academy of Dermatology 75:4, pages 740-746.
Crossref
Crossref
Giulia Ganzetti, Anna Campanati, Andrea Santarelli, Davide Sartini, Elisa Molinelli, Valerio Brisigotti, Giulia Di Ruscio, Ivan Bobyr, Monica Emanuelli & Annamaria Offidani. (2016) Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. Journal of International Medical Research 44:1_suppl, pages 10-14.
Crossref
Crossref
Maurizio Pompili, Marco Innamorati, Sara Trovarelli, Alessandra Narcisi, Samantha Bellini, Diego Orsini, Alberto Forte, Denise Erbuto, Elisabetta Botti, Dorian A Lamis, Paolo Girardi & Antonio Costanzo. (2016) Suicide risk and psychiatric comorbidity in patients with psoriasis. Journal of International Medical Research 44:1_suppl, pages 61-66.
Crossref
Crossref
Sudharsana Sundarrajan & Mohanapriya Arumugam. (2016) Comorbidities of Psoriasis - Exploring the Links by Network Approach. PLOS ONE 11:3, pages e0149175.
Crossref
Crossref
Alessandro Mantovani, Paolo Gisondi, Amedeo Lonardo & Giovanni Targher. (2016) Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?. International Journal of Molecular Sciences 17:2, pages 217.
Crossref
Crossref
Dongze Wu, Deshun Shi, Li Yang & Xiaoliang Zhu. (2015) Association between methylenetetrahydrofolate reductase C677T polymorphism and psoriasis: A meta‐analysis. The Journal of Dermatology 43:2, pages 162-169.
Crossref
Crossref
Xi DuanYan ChengLinbo GaoLijuan LiTao WangMin Zhang. (2016)
Evaluation of the Potential Association between NOS Gene Polymorphisms (
iNOS G-954C
and
eNOS G894T
) and Psoriasis
. Annals of Dermatology 28:1, pages 110.
Crossref
Crossref
Somesh Sharma, Kailash Bhatia, Meetesh Agarwal, Sandesh Gupta, Leelavathi Budamakuntla, Sudhakar Grandhi, Vinod Titarmare, Sushil Pande, Ranjan Rawal, Aruna Samarth, Rizwan Haq, Vikrant Saoji, D. V. S. Pratap, L. M. Kansal, D. G. Saple, Shatrughan Sahay, Parag Kalyani, Puneet Goyal, Sharmila Patil, A. J. Kanwar, Bhavesh Swarnakar, Sujay Kulkarni, Abhijeet Morde, Hitesh Khandagale, Yogesh Dound, Nitin Jadhav, Sanjeev Hegde, Murlidhara Padigaru & Ashish C. Suthar. (2016) Efficacy and Safety of Tinefcon<sup>®</sup> Tablets in Subjects with Plaque Psoriasis: An Open Label, Non-Comparative, Multicenter, Phase IV Trial. Journal of Cosmetics, Dermatological Sciences and Applications 06:02, pages 55-66.
Crossref
Crossref
Vinay Singh. (2016) Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions. Dermatology Research and Practice 2016, pages 1-4.
Crossref
Crossref
Lakshi M. Aldredge & Melodie S. Young. (2016) Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy. Journal of the Dermatology Nurses' Association 8:1, pages 14-26.
Crossref
Crossref
D. Linder, G. Altomare, S. Amato, P. Amerio, N. Balato, A. Campanati, A. Conti, P. Gisondi, F. Prignano, R. Saraceno & S. Piaserico. (2015) PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence-based algorithm. Journal of the European Academy of Dermatology and Venereology 29:7, pages 1310-1317.
Crossref
Crossref
L.-T. Kao, K.-H. Wang, H.-C. Lin, H.-C. Li, S. Yang & S.-D. Chung. (2015) Use of health care services by patients with psoriasis: a population-based study. British Journal of Dermatology 172:5, pages 1346-1352.
Crossref
Crossref
Matthias Augustin, Marc A. Radtke, Gerd Glaeske, Kristian Reich, Enno Christophers, Ines Schaefer & Arnd Jacobi. (2015) Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema. Dermatology 231:1, pages 35-40.
Crossref
Crossref
Marisa Kardos Garshick & Alexa Boer Kimball. (2015) Psoriasis and the Life Cycle of Persistent Life Effects. Dermatologic Clinics 33:1, pages 25-39.
Crossref
Crossref
Li-Ting Kao, Cha-Ze Lee, Shih-Ping Liu, Ming-Chieh Tsai & Herng-Ching Lin. (2014) Psoriasis and the Risk of Pneumonia: A Population-Based Study. PLoS ONE 9:12, pages e116077.
Crossref
Crossref
Robert L Boggs, Sarolta Kárpáti, Wenzhi Li, Theresa Williams, Ronald Pedersen, Lotus Mallbris & Robert Gniadecki. (2014) Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment. BMC Dermatology 14:1.
Crossref
Crossref
Burhan Engin, Zekayi Kutlubay, Gürkan Yardımcı, Hayriye Ertem Vehid, Pınar Ambarcıoğlu, Server Serdaroğlu & Yalçın Tüzün. (2014) Evaluation of body composition parameters in patients with psoriasis. International Journal of Dermatology 53:12, pages 1468-1473.
Crossref
Crossref
M.H. Larsen, A.L. Krogstad, E. Aas, T. Moum & A.K. Wahl. (2014) A telephone-based motivational interviewing intervention has positive effects on psoriasis severity and self-management: a randomized controlled trial. British Journal of Dermatology 171:6, pages 1458-1469.
Crossref
Crossref
Jacek Karczewski, Barbara Poniedziałek, Piotr Rzymski & Zygmunt Adamski. (2014) Factors affecting response to biologic treatment in psoriasis. Dermatologic Therapy 27:6, pages 323-330.
Crossref
Crossref
P.A. Nelson, C. Keyworth, A. Chisholm, C.J. Pearce, C.E.M. Griffiths, L. Cordingley & C. Bundy. (2014)
‘In someone's clinic but not in
mine
’ – clinicians’ views of supporting lifestyle behaviour change in patients with psoriasis: a qualitative interview study
. British Journal of Dermatology 171:5, pages 1116-1122.
Crossref
Crossref
Rosario Fátima Lafuente-Urrez, Juan José Beloqui-Lizaso, Beatriz Larrayoz-Sola & Julio Pérez-Pelegay. (2014) Estudio retrospectivo de la eficacia y seguridad de adalimumab en el tratamiento de la psoriasis en la práctica clínica diaria. Piel 29:8, pages 468-476.
Crossref
Crossref
M. Asefi, A. Vaisi‐Raygani, R. Khodarahmi, H. Nemati, Z. Rahimi, H. Vaisi‐Raygani, H. Tavilani & T. Pourmotabbed. (2013) Methylentetrahydrofolatereductase (rs1801133) polymorphism and psoriasis: contribution to oxidative stress, lipid peroxidation and correlation with vascular adhesion protein 1, preliminary report. Journal of the European Academy of Dermatology and Venereology 28:9, pages 1192-1198.
Crossref
Crossref
C. De Simone, G. Caldarola, V. Coco, S. Palumbo, K. Pocino, A. Sgambato, A. Maiorino, M. Corbi, M.T. Sandri, F. Vendittelli & E. Capoluongo. (2014) Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment. Journal of the European Academy of Dermatology and Venereology 28:5, pages 590-596.
Crossref
Crossref
M.T.P. Evangelista, M.F.A. Casintahan & L.L. Villafuerte. (2014) Simvastatin as a novel therapeutic agent for venous ulcers: a randomized, double-blind, placebo-controlled trial. British Journal of Dermatology 170:5, pages 1151-1157.
Crossref
Crossref
Raghda Ghonimy Elsheikh, Tarek El-Sayed Amin, Amal Ahmad El-Ashmawy & Samah Ibrahim Abd El-fttah Abdalla. (2014) Evaluation of subclinical atherosclerosis in Egyptian psoriatic patients. Journal of the Saudi Heart Association 26:2, pages 63-71.
Crossref
Crossref
Nemati Houshang, Khodarahmi Reza, Sadeghi Masoud, Ebrahimi Ali, Rezaei Mansour & Asad Vaisi-Raygani. (2014) Antioxidant status in patients with psoriasis. Cell Biochemistry and Function 32:3, pages 268-273.
Crossref
Crossref
A.B. Kimball, J. Schenfeld, N.A. Accortt, M.S. Anthony, K.J. Rothman & D. Pariser. (2014) Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005–09. British Journal of Dermatology 170:2, pages 366-373.
Crossref
Crossref
Marie Hamilton Larsen, Kåre Birger Hagen, Anne-Lene Krogstad, Eline Aas & Astrid Klopstad Wahl. (2014) Limited evidence of the effects of patient education and self-management interventions in psoriasis patients: A systematic review. Patient Education and Counseling 94:2, pages 158-169.
Crossref
Crossref
Ramya Tripuraneni & Francisco Kerdel. 2014. Nail Psoriasis. Nail Psoriasis
23
31
.
Deepak K. Rajpal, Xiaoyan A. Qu, Johannes M. Freudenberg & Vinod D. Kumar. 2014. Biomedical Literature Mining. Biomedical Literature Mining
171
206
.
Emerson de Andrade Lima, Mariana Modesto Dantas de Andrade Lima, Cláudia Diniz Lopes Marques, Angela Luzia Branco Pinto Duarte, Ivan da Rocha Pita & Maira Galdino da Rocha Pita. (2013) Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis. Anais Brasileiros de Dermatologia 88:6, pages 1029-1035.
Crossref
Crossref
Pauline A Nelson, Zoë Barker, Christopher EM Griffiths, Lis Cordingley & Carolyn A Chew-Graham. (2013) ‘On the surface’: a qualitative study of GPs’ and patients’ perspectives on psoriasis. BMC Family Practice 14:1.
Crossref
Crossref
Katerina Damevska, Lence Neloska, Gjeorgji Gocev & Marija Mihova. (2013) Cardiovascular and Metabolic Comorbidities in Patients with Plaque-Type Psoriasis Never Treated with Systemic Antipsoriatic Drugs: a Case-Control Study. Serbian Journal of Dermatology and Venerology 5:2, pages 53-64.
Crossref
Crossref
John Berth-Jones. (2013) Psoriasis. Medicine 41:6, pages 334-340.
Crossref
Crossref
Jau-Jiuan Sheu, Kuo-Hsien Wang, Herng-Ching Lin & Chung-Chien Huang. (2013) Psoriasis is associated with an increased risk of parkinsonism: A population-based 5-year follow-up study. Journal of the American Academy of Dermatology 68:6, pages 992-999.
Crossref
Crossref
K. Papp, A. Menter, Y. Poulin, Y. Gu & E.H. Sasso. (2013) Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension study. Journal of the European Academy of Dermatology and Venereology 27:5, pages 634-642.
Crossref
Crossref
P.A. Nelson, C.A. Chew-Graham, C.E.M. Griffiths & L. Cordingley. (2013) Recognition of need in health care consultations: a qualitative study of people with psoriasis. British Journal of Dermatology 168:2, pages 354-361.
Crossref
Crossref
Chris S BakerPeter A FoleyAnna Braue. (2013)
Psoriasis uncovered – measuring burden of disease impact in a survey of
A
ustralians with psoriasis
. Australasian Journal of Dermatology 54:S1, pages 1-6.
Crossref
Crossref
Cho Rok KimJoo-Heung Lee. (2013) An Observational Study on the Obesity and Metabolic Status of Psoriasis Patients. Annals of Dermatology 25:4, pages 440.
Crossref
Crossref
Houshang Nemati, Reza Khodarahmi, Ameneh Rahmani, Ali Ebrahimi, Mojtaba Amani & Kamran Eftekhari. (2013) Serum lipid profile in psoriatic patients: correlation between vascular adhesion protein 1 and lipoprotein (a). Cell Biochemistry and Function 31:1, pages 36-40.
Crossref
Crossref
Noori Kim, Brienne Cressey, Michael Do, Rona Wang, Alice B. Gottlieb & Paul F. Lizzul. (2018) Impact of Accountable Care Organizations on Psoriasis Care. Psoriasis Forum 18a:4, pages 221-224.
Crossref
Crossref
M. Asefi, A. Vaisi‐Raygani, F. Bahrehmand, A. Kiani, Z. Rahimi, H. Nomani, A. Ebrahimi, H. Tavilani & T. Pourmotabbed. (2012) Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis. British Journal of Dermatology 167:6, pages 1279-1286.
Crossref
Crossref
J.J. Keller & H.‐C. Lin. (2012) The effects of chronic periodontitis and its treatment on the subsequent risk of psoriasis. British Journal of Dermatology 167:6, pages 1338-1344.
Crossref
Crossref
R. Gniadecki, D. Robertson, C.T. Molta, B. Freundlich, R. Pedersen, W. Li, R. Boggs & A.S. Zbrozek. (2012) Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens. Journal of the European Academy of Dermatology and Venereology 26:11, pages 1436-1443.
Crossref
Crossref
C. Ferrándiz, A. García, A.J. Blasco & P. Lázaro. (2012) Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology 26:6, pages 768-777.
Crossref
Crossref
A.M. Binus, J. Han, A.A. Qamar, E.A. Mody, E.W. Holt & A.A. Qureshi. (2012) Associated comorbidities in psoriasis and inflammatory bowel disease. Journal of the European Academy of Dermatology and Venereology 26:5, pages 644-650.
Crossref
Crossref
Gayathri K. PereraPaola Di MeglioFrank O. Nestle. (2012) Psoriasis. Annual Review of Pathology: Mechanisms of Disease 7:1, pages 385-422.
Crossref
Crossref
Kenneth Gordon, Kim Papp, Yves Poulin, Yihua Gu, Stephen Rozzo & Eric H. Sasso. (2012) Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL. Journal of the American Academy of Dermatology 66:2, pages 241-251.
Crossref
Crossref
Kai Li & April W. Armstrong. (2012) A Review of Health Outcomes in Patients with Psoriasis. Dermatologic Clinics 30:1, pages 61-72.
Crossref
Crossref
Emerson de Andrade Lima & Mariana de Andrade Lima. (2011) Imunopatogênese da psoríase: revisando conceitos. Anais Brasileiros de Dermatologia 86:6, pages 1151-1158.
Crossref
Crossref
Janice A. Husted, Arane Thavaneswaran, Vinod Chandran, Lihi Eder, Cheryl F. Rosen, Richard J. Cook & Dafna D. Gladman. (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis. Arthritis Care & Research 63:12, pages 1729-1735.
Crossref
Crossref
Pejman Khanifam, Kristin M. Kolltveit, Cato Mørk, Per Gjermo & Hans Ragnar Preus. (2011) Periodontitt hos pasienter med psoriasis. Den norske tannlegeforenings Tidende 121:10.
Crossref
Crossref
LAURA DI RENZO, ROSITA SARACENO, CATERINA SCHIPANI, MARIAGIOVANNA RIZZO, ALESSIA BIANCHI, ANNALISA NOCE, MARIA ESPOSITO, SERGIO TIBERTI, SERGIO CHIMENTI & ANTONINO DE LORENZO. (2011) Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment. Dermatologic Therapy 24:4, pages 446-451.
Crossref
Crossref
JC Prinz, O FitzGerald, RL Boggs, J Foehl, D Robertson, R Pedersen, CT Molta & B Freundlich. (2011) Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. Journal of the European Academy of Dermatology and Venereology 25:5, pages 559-564.
Crossref
Crossref
KS Wenk, KC Arrington & A Ehrlich. (2011) Psoriasis and non-alcoholic fatty liver disease. Journal of the European Academy of Dermatology and Venereology 25:4, pages 383-391.
Crossref
Crossref
Alexandra K. Golant & Emma Guttman-Yassky. (2018) Psoriasis Treatments: A Review of the Current Research Pipeline. Psoriasis Forum 17a:1, pages 11-23.
Crossref
Crossref
Alexa B. Kimball, Arielle G. Bensimon, Annie Guerin, Andrew P. Yu, Eric Q. Wu, Martin M. Okun, Yanjun Bao, Shiraz R. Gupta & Parvez M. Mulani. (2011) Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities. American Journal of Clinical Dermatology 12:1, pages 51-62.
Crossref
Crossref
AB Kimball, A Guérin, M Tsaneva, AP Yu, EQ Wu, SR Gupta, Y Bao & PM Mulani. (2011) Economic burden of comorbidities in patients with psoriasis is substantial. Journal of the European Academy of Dermatology and Venereology 25:2, pages 157-163.
Crossref
Crossref
Kim A. Papp, James Signorovitch, Karthik Ramakrishnan, Andrew P. Yu, Shiraz R. Gupta, Yanjun Bao & Parvez M. Mulani. (2011) Effects of Adalimumab versus Placebo on Risk of Symptom Worsening in Psoriasis and Subsequent Impacts on Health-Related Quality-of-Life. Clinical Drug Investigation 31:1, pages 51-60.
Crossref
Crossref
Lisa Wenyang Fu & Ronald Vender. (2011) Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome. Dermatology Research and Practice 2011, pages 1-4.
Crossref
Crossref
Yves Poulin, Kim A. Papp, Norman R. Wasel, Robin Andrew, Elisa Fraquelli, Geula Bernstein & Daphne Chan. (2010) A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis. International Journal of Dermatology 49:12, pages 1368-1375.
Crossref
Crossref
James E. Signorovitch, Eric Q. Wu, Andrew P. Yu, Charles M. Gerrits, Evan Kantor, Yanjun Bao, Shiraz R. Gupta & Parvez M. Mulani. (2010) Comparative Effectiveness Without Head-to-Head Trials. PharmacoEconomics 28:10, pages 935-945.
Crossref
Crossref
Tracey Wheeler. (2010) Prescribing for psoriasis: choosing the best option. Nurse Prescribing 8:10, pages 482-490.
Crossref
Crossref
PA Foley, C Quirk, JR Sullivan, C Dolianitis, SP Hack, K Thirunavukkarasu & AJ Cooper. (2010) Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence. Journal of the European Academy of Dermatology and Venereology 24:10, pages 1135-1143.
Crossref
Crossref
Nora Kogan, Rosana Veira, Elena Chaparro, Alejandra Crespo, Simón Gusis & Mercedes Hassan. (2018) Comorbidities in Psoriasis. Psoriasis Forum 16a:3, pages 23-30.
Crossref
Crossref
Alan Menter, Kenneth B. Gordon, Craig L. Leonardi, Yihua Gu & Orin M. Goldblum. (2010) Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis. Journal of the American Academy of Dermatology 63:3, pages 448-456.
Crossref
Crossref
J Schmitt & DE Ford. (2010) Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population‐based sample. Journal of the European Academy of Dermatology and Venereology 24:8, pages 885-892.
Crossref
Crossref
Kim Papp, Fernando Valenzuela, Yves Poulin, Geula Bernstein & Norman Wasel. (2010) Epidemiology of Moderate-to-Severe Plaque Psoriasis in a Canadian Surveyed Population. Journal of Cutaneous Medicine and Surgery 14:4, pages 167-174.
Crossref
Crossref
Tiffany Kwok, Wei Jing Loo & Lyn Guenther. (2010) Psoriasis and Multiple Sclerosis: Is There a Link?. Journal of Cutaneous Medicine and Surgery 14:4, pages 151-155.
Crossref
Crossref
Marc Alexander Radtke, Jobst Augustin, Christine Blome, Kristian Reich, Stephan J. Rustenbach, Ines Schäfer, Anna Laass & Matthias Augustin. (2010) How do regional factors influence psoriasis patient care in Germany?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 8:7, pages 516-523.
Crossref
Crossref
S Coimbra, H Oliveira, F Reis, L Belo, S Rocha, A Quintanilha, A Figueiredo, F Teixeira, E Castro, P Rocha‐Pereira & A Santos‐Silva. (2010)
C‐reactive protein and leucocyte activation in psoriasis
vulgaris
according to severity and therapy
. Journal of the European Academy of Dermatology and Venereology 24:7, pages 789-796.
Crossref
Crossref
J.P. McFadden, B.S. Baker, A.V. Powles & L. Fry. (2010) Psoriasis and extra domain A fibronectin loops. British Journal of Dermatology 163:1, pages 5-11.
Crossref
Crossref
Sara Alonso Castro, Rubén Queiro Silva, Mónica Fernandez Serna, Mercedes Alperi López, Jose Luis Riestra Noriega & Francisco Javier Ballina García. (2010) Comorbilidades en las espondiloartropatías. Seminarios de la Fundación Española de Reumatología 11:3, pages 89-93.
Crossref
Crossref
Srdjan Prodanovich, Carlos Ricotti, Brad P. Glick, Luca Inverardi, Craig L. Leonardi & Francisco Kerdel. (2010) Etanercept: An Evolving Role in Psoriasis and Psoriatic Arthritis. American Journal of Clinical Dermatology 11, pages 3-9.
Crossref
Crossref
Alan Menter, Matthias Augustin, James Signorovitch, Andrew P. Yu, Eric Q. Wu, Shiraz R. Gupta, Yanjun Bao & Parvez Mulani. (2010) The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial. Journal of the American Academy of Dermatology 62:5, pages 812-818.
Crossref
Crossref
J.C. Moreno-Giménez, R. Jiménez-Puya & M. Galán-Gutiérrez. (2010) Comorbilidades en psoriasis. Actas Dermo-Sifiliográficas 101, pages 55-61.
Crossref
Crossref
M. Carlesimo, E. Mari, A. Arcese, F. De Angelis, E. Palese, C. Abruzzese, G. De Marco, M.S. Cattaruzza & G. Camplone. (2010) Safety and Efficacy of Calcium Folinate in Psoriasis: An Observational Study. International Journal of Immunopathology and Pharmacology 23:2, pages 649-653.
Crossref
Crossref
AB Kimball, U Gieler, D Linder, F Sampogna, RB Warren & M Augustin. (2010) Psoriasis: is the impairment to a patient’s life cumulative?. Journal of the European Academy of Dermatology and Venereology, pages no-no.
Crossref
Crossref
Alexa Boer Kimball, Annie Guerin, Dominick Latremouille-Viau, Andrew P. Yu, Shiraz Gupta, Yanjun Bao & Parvez Mulani. (2010) Coronary Heart Disease and Stroke Risk in Patients with Psoriasis: Retrospective Analysis. The American Journal of Medicine 123:4, pages 350-357.
Crossref
Crossref
Honghui Zhou, Chuanpu Hu, Yaowei Zhu, Ming Lu, Sam Liao, Newman Yeilding & Hugh M. Davis. (2013) Population‐Based Exposure‐Efficacy Modeling of Ustekinumab in Patients With Moderate to Severe Plaque Psoriasis. The Journal of Clinical Pharmacology 50:3, pages 257-267.
Crossref
Crossref
Mohammed Ahmed Alsufyani, Alexandra K. Golant & Mark Lebwohl. (2010) Psoriasis and the metabolic syndrome. Dermatologic Therapy 23:2, pages 137-143.
Crossref
Crossref
M. Augustin, G. Glaeske, M.A. Radtke, E. Christophers, K. Reich & I. Schäfer. (2010) Epidemiology and comorbidity of psoriasis in children. British Journal of Dermatology 162:3, pages 633-636.
Crossref
Crossref
Tracey Wheeler. (2010) Psoriasis: impact and management of moderate to severe disease. British Journal of Nursing 19:1, pages 10-17.
Crossref
Crossref
Alice B. Gottlieb & Frank Dann. (2009) Comorbidities in Patients with Psoriasis. The American Journal of Medicine 122:12, pages 1150.e1-1150.e9.
Crossref
Crossref
W.H. Boehncke & S. Boehncke. (2009) Managing Comorbidities in Psoriasis. Actas Dermo-Sifiliográficas 100, pages 22-27.
Crossref
Crossref
Ronald Mahler, Christine Jackson & Horia Ijacu. (2009) The Burden of Psoriasis and Barriers to Satisfactory Care: Results from a Canadian Patient Survey. Journal of Cutaneous Medicine and Surgery 13:6, pages 283-293.
Crossref
Crossref
A.J. Blasco, P. Lázaro, C. Ferrándiz, A. García-Díez & J. Liso. (2009) Efficiency of Biologic Agents in the Treatment of Moderate to Severe Psoriasis. Actas Dermo-Sifiliográficas (English Edition) 100:9, pages 792-803.
Crossref
Crossref
A.J. Blasco, P. Lázaro, C. Ferrándiz, A. García-Díez & J. Liso. (2009) Eficiencia de los agentes biológicos en el tratamiento de la psoriasis moderada-grave. Actas Dermo-Sifiliográficas 100:9, pages 792-803.
Crossref
Crossref
Lyn Guenther & Wayne Gulliver. (2009) Psoriasis Comorbidities. Journal of Cutaneous Medicine and Surgery 13:5_suppl, pages S77-S87.
Crossref
Crossref
TA Luger, J Barker, J Lambert, S Yang, D Robertson, J Foehl, CT Molta & R Boggs. (2009) Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis. Journal of the European Academy of Dermatology and Venereology 23:8, pages 896-904.
Crossref
Crossref
Thao NguyenJohn Koo. (2018) Purine Synthesis Inhibitors, 6-thioguanine and Azathioprine: Forgotten Treatment Options in Psoriasis and Psoriatic Arthritis. Psoriasis Forum 15a:1, pages 23-30.
Crossref
Crossref
John Berth-Jones. (2009) Psoriasis. Medicine 37:5, pages 235-241.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Lipidology 20:2, pages 135-142.
Crossref
Crossref
Jose L. Sánchez Carazo, Pablo Hernández Bel & Víctor Alegre de Miguel. (2009) Psoriasis y calidad de vida. Piel 24:1, pages 1-3.
Crossref
Crossref
Vincent E. Friedewald, Jennifer C. Cather, Joel M. Gelfand, Kenneth B. Gordon, Gary H. Gibbons, Scott M. Grundy, Michael T. Jarratt, James G. Krueger, Paul M. Ridker, Neil Stone & William C. Roberts. (2008) AJC Editor's Consensus: Psoriasis and Coronary Artery Disease. The American Journal of Cardiology 102:12, pages 1631-1643.
Crossref
Crossref
. (2008) Infliximab rescue of efalizumab withdrawal flare and psoriasis-precipitated depression. Australasian Journal of Dermatology 49:4, pages 250-251.
Crossref
Crossref
Stephen K. Richardson & Joel M. Gelfand. (2008) Update on the Natural History and Systemic Treatment of Psoriasis. Advances in Dermatology 24, pages 171-196.
Crossref
Crossref
Jana Kazandjieva, Ivan Grozdev, Razvigor Darlenski & Nikolai Tsankov. (2008) Climatotherapy of psoriasis. Clinics in Dermatology 26:5, pages 477-485.
Crossref
Crossref
Brenda L Bartlett & Stephen K Tyring. (2008) Ustekinumab for chronic plaque psoriasis. The Lancet 371:9625, pages 1639-1640.
Crossref
Crossref